FPMI (FPMI) Stock Price & Analysis
FPMI (FPMI) rose 0.00% to USD 0 as of June 10, 2026 at 05:56 UTC, according to Nexqual real-time market data.
FPMI last closed at USD 0; the session ranged USD 0–0 on volume of 1,188,100 shares. Market capitalization is $6,852, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 05:56 UTC.
Key Statistics (as of June 10, 2026 at 05:56 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 1,188,100 shares |
| Market Cap | $6,852 |
| Exchange | PNK |
Technical Analysis (FPMI)
Nexqual's technical model rates FPMI "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 05:56 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (FPMI)
Wall Street analysts rate FPMI "None", per Nexqual as of June 10, 2026 at 05:56 UTC.
| Consensus Rating | None |
|---|
Earnings (FPMI)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2015-06-30 | USD -0.05 vs est -0.06 ▲ beat |
| 2015-03-31 | USD -0.02 vs est -0.05 ▲ beat |
| 2014-12-31 | USD 0 vs est -0.07 ▲ beat |
| 2014-09-30 | USD -0.04 vs est -0.05 ▲ beat |
Source: Nexqual, June 10, 2026 at 05:56 UTC.
Financials & Fundamentals (FPMI)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.01 |
| Total Cash | $24,723 |
| Total Debt | $5.82M |
| Free Cash Flow | $-780,865 |
Source: Nexqual, June 10, 2026 at 05:56 UTC.
Financial Health Score (FPMI)
Nexqual rates FPMI's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 05:56 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $25K cash vs $6M debt |
| Cash Flow | Weak — Operating cash flow -$880K |
| Efficiency | Mixed — No data |
Ownership (FPMI)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 34.26M |
| Float | 30.66M |
Source: Nexqual, June 10, 2026 at 05:56 UTC.
Leadership (FPMI)
FPMI is led by Edward L. Lyons, Vice President of Development, per Nexqual as of June 10, 2026 at 05:56 UTC.
| Vice President of Development | Edward L. Lyons |
|---|
Major Backers & Investors (FPMI)
Notable institutional backers of FPMI include Williams Jones Wealth Management, LLC., according to Nexqual as of June 10, 2026 at 05:56 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Williams Jones Wealth Management, LLC. | 0.43% |
Source: Nexqual, June 10, 2026 at 05:56 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ARNI | ARNO THERAPEUTICS INC | USD 0 | ▲ 0% |
| AOLS | AEOLUS PHARMACEUTICALS INC | USD 0 | ▲ 0% |
| CDXI | CARDAX INC | USD 0 | ▲ 0% |
| ERGO | Entia Biosciences Inc. | USD 0 | ▲ 0% |
| GTHP | Guided Therapeutics, Inc. | USD 0.2 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:56 UTC. This page is informational and not investment advice.